Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

Phylex Vaccine On Track To Combat Deadly NIPAH Virus With Positive Results Of Immunogenicity Study

Phylex Biosciences has achieved positive results with its new mRNA nanoparticle vaccine against the Nipah virus in an immunogenicity study conducted in collaboration with scientists of the U.S. Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia.

August 6, 2024


April 8 2026

April 7 2026

April 6 2026

April 5 2026

April 4 2026

April 3 2026

April 2 2026

April 1 2026

March 31 2026

March 30 2026

March 29 2026

March 28 2026

March 27 2026

March 26 2026

March 25 2026